Compare NexGenix Pharmaceuticals Holdings vs Virdante Pharmaceuticals
Customers evaluate the quality of NexGenix Pharmaceuticals Holdings's products using the following success metrics.
Overview
NexGenix Pharmaceuticals Holdings is 21 yrs old and is based in United States.
NexGenix Pharmaceuticals is developing drugs for cancer, neurodegenerative diseases, and neurofibromatosis.
Virdante Pharmaceuticals is based in United States
Virdante Pharmaceuticals is developing safer and more effective drugs for autoimmune and inflammatory diseases. The company's products incorporate a proprietary sialic switch technology to improve the anti-inflammatory properties of antibodies.
Demo Video
Leadership
Laura A Philips (Chief Financial Officer, Chief Operating Officer)
John Ripple (Chief Executive Officer)
Funding
Investors
Venrock, Biogen Idec New Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because NexGenix Pharmaceuticals Holdings has not claimed their profile.
Work for NexGenix Pharmaceuticals Holdings? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for NexGenix Pharmaceuticals Holdings?
Claim your profile now.
Information not available because Virdante Pharmaceuticals has not claimed their profile.
Work for Virdante Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Virdante Pharmaceuticals?
Claim your profile now.